Biotech news
Biotech
Finnish health tech firm says Ultrahuman’s motion to stay would significantly prejudice case | Oura claims Indian company trying to circumvent ITC exclusion order. 13 June 2024
Biotech
Complaint sought judicial validation of the company's patent claims for a distributive shock treatment | Disputes the PTAB's decision deeming the invention obvious. 6 June 2024
Careers
ABG IP says the promotions recognise staff performance, improve gender equality and lower the average age among partners, and secure its values and position in the market. 4 June 2024
Americas
US and Indian firms reach agreement to settle US litigation and UK arbitration | HDT had accused Emcure of trade secrets theft over COVID-19 vaccine technology. 28 May 2024
Biotech
New Jersey federal judge said Acuitas had failed to show case or controversy | Acuitas had sought declaratory judgment that Pfizer’s Comirnaty vaccine did not infringe patents. 23 May 2024
Biotech
ARP maintained rejection of two claims of Xencor’s antibodies patent application | Panel clarified specification for means-plus-function claim limitations. 21 May 2024
Biotech
Despite attempts by Pfizer and BioNTech to invalidate the patent, the ruling strengthens Moderna’s position in ongoing global litigation | Pfizer is considering an appeal, while BioNTech remains steadfast in defending its innovations. 21 May 2024
Biotech
Puritan Medical argued it had immunity under PREP Act in patent suit | Fed Circ said the district court had not conclusively determined any issue. 16 May 2024
Europe
Biotech firm to ask Munich court to permanently lift injunction on CosMx products following ruling | Judgment comes a day after acquisition by Bruker was finalised. 9 May 2024
Americas
Two-day event in Boston brings together leading in-house patent counsel | Regeneron, USPTO, the Broad Institute and Novartis among attendees I Agenda includes the UPC, patent strategies, and multijurisdictional patent litigation | Registrations for LSPN Fall now open. 7 May 2024